The National Health Insurance Civilian Surveillance Alliance yesterday questioned the legitimacy of a certification for pharmaceutical manufacturers after a majority of the manufacturers that were required by the Food and Drug Administration (FDA) to re-file bioequivalence testing (BE) reports for changes made to their products were awarded PIC/S GMP or GMP certification.
BE testing is conducted to ensure that a generic drug delivers the same therapeutic effect as a reference brand-name pharmaceutical.
In response, the agency said that the changes to the drugs were “legitimate” and have no negative impact on drug safety.
Photo: Wei Yi-chia, Taipei Times
At the end of August, the health insurance watchdog held a press conference to report that as many as 3,841 drug products failed to comply with pharmaceutical regulations after making changes to package inserts, packaging and the excipients used in drugs without seeking re-approval by the regulator.
In response, the agency promised to hold risk assessment meetings to evaluate the drugs that had been altered.
This month, the agency announced that 33 out of 3,841 generic drug products would need to be tested for their bioequivalence with brand-name medicines, with 21 more to be examined.
The group found that 10 of the 11 drug manufacturers that produce the 33 drugs are PIC/S GMP (Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme, or the guide to Good Manufacturing Practice for medicinal products) or GMP certified.
“The government has required all pharmaceutical manufacturers to be PIC/S-certified by the end of next year, after which those without will not be permitted to make or sell drugs in Taiwan,” alliance spokeswoman Eva Teng (滕西華) said.
“However, the 10 manufacturers account for 15.8 percent of the 57 PIC/S GMP-certified manufacturers in the country. This makes us concerned that the certification does not guarantee drug quality,” Teng added.
The lack of BE testing reports for drugs that have been altered is a major problem, the group said.
“Changing the excipient, the diluent or the vehicle of a drug could decrease its therapeutic effect,” alliance convener Huang Sue-ying (黃淑英) said, adding that the agency should have ordered that the 33 drug products be pulled off shelves immediately after the announcement this month.
“The agency asked doctors to look for substitutes as soon as possible, and said that the drugs were without health risks,” she said.
FDA official Chi Jo-feng (祁若鳳) said that the PIC/S GMP certificate would not be revoked unless the violations are “grave,” such as producing counterfeit drugs, adding that the drugs were not withdrawn from the market immediately because some patients need time to switch to a new drug.
The agency updated the list in a statement yesterday, announcing the final result of the assessment for the need of BE testing on a total of 54 drugs (including the 33 announced earlier), which said that only nine of the 54 would need to redo BE testing.
One of the 33 drugs required to be tested this month was made exempt because the manufacturer had subsequently handed in relevant documents, while several others decided to revert to the original formula or simply give up the permit for the drug and had their products pulled off shelves, an FDA official said.
SPACE VETERAN: Kjell N. Lindgren, who helps lead NASA’s human spaceflight missions, has been on two expeditions on the ISS and has spent 311 days in space Taiwan-born US astronaut Kjell N. Lindgren is to visit Taiwan to promote technological partnerships through one of the programs organized by the US for its 250th national anniversary. Lindgren would be in Taiwan from Tuesday to Saturday next week as part of the US Bureau of Educational and Cultural Affairs’ US Speaker Program, organized to celebrate the 250th anniversary of the signing of the Declaration of Independence, the American Institute in Taiwan (AIT) said in a statement yesterday. Lindgren plans to engage with key leaders across the nation “to advance cutting-edge technological partnerships and inspire the next generation of scientists and engineers,”
UNREASONABLE SURVEILLANCE: A camera targeted on an road by a neighbor captured a man’s habitual unsignaled turn into home, netting him dozens of tickets The Taichung High Administrative Court has canceled all 45 tickets given to a man for failing to use a turn signal while driving, as it considered long-term surveillance of his privacy more problematic than the traffic violations. The man, surnamed Tseng (曾), lives in Changhua County and was reported 45 times within a month for failing to signal while driving when he turned into the alley where his residence is. The reports were filed by his neighbor, who set up security cameras that constantly monitored not only the alley but also the door and yard of Tseng’s house. The surveillance occurred from July
A Japan Self-Defense Forces vessel entered the Taiwan Strait yesterday, Japanese media reported. After passing through the Taiwan Strait, the Ikazuchi was to proceed to the South China Sea to take part in a joint military exercise with the US and the Philippines, the reports said. Japan Self-Defense Force vessels were first reported to have passed through the strait in September, 2024, with two further transits taking place in February and June last year, the Asahi Shimbun reported. Yesterday’s transit also marked the first time since Japanese Prime Minister Sanae Takaichi took office that a Japanese warship has been sent through the Taiwan
‘SAME OLD TRICK’: Even if Beijing resumes individual travel to Taiwan, it would only benefit Chinese tourism companies, the Economic Democracy Union convener said China’s 10 new “incentives” are “sugar-coated poison,” an official said yesterday, adding that Taiwanese businesses see them clearly for what they are, but that Beijing would inevitably find some local collaborators to try to drums up support. The official, speaking on condition of anonymity, made the remark ahead of a news conference the General Chamber of Commerce is to hold today. The event, titled “Industry Perspectives on China’s Recent Pro-Taiwan Policies,” is expected to include representatives from industry associations — such as those in travel, hotels, food and agriculture — to request the government cooperate with China’s new measures, people familiar with
RSS